BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15272314)

  • 21. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
    van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
    Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB; Liu JM; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
    Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
    Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
    Yang BW; Liang Y; Xia JL; Sun HC; Wang L; Zhang JB; Tang ZY; Liu KD; Chen J; Xue Q; Chen J; Gao DM; Wu WZ
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1077-84. PubMed ID: 19047839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
    Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
    Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
    Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin.
    Oda A; Katayose Y; Yabuuchi S; Yamamoto K; Mizuma M; Shirasou S; Onogawa T; Ohtsuka H; Yoshida H; Hayashi H; Rikiyama T; Kim H; Choe Y; Kim K; Son H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1201-9. PubMed ID: 19414365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.
    Ko YJ; Devi GR; London CA; Kayas A; Reddy MT; Iversen PL; Bubley GJ; Balk SP
    J Urol; 2004 Sep; 172(3):1140-4. PubMed ID: 15311058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular target-based therapy of pancreatic cancer.
    Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
    Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High mobility group A1 expression correlates with the histological grade of human glial tumors.
    Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
    Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster.
    Hara H; Kobayashi A; Yoshida K; Ohashi M; Ohnami S; Uchida E; Higashihara E; Yoshida T; Aoki K
    Cancer Sci; 2007 Mar; 98(3):455-63. PubMed ID: 17233811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
    Deharvengt S; Wack S; Aprahamian M; Hajri A
    J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of transferring DPC4-adenovirus on pancreatic adenocarcinoma cells].
    Feng XL; Zhang ZD; Tian L; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):607-11. PubMed ID: 15460398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
    Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
    Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.